Context Therapeutics Inc. is a biopharmaceutical company focused on advancing innovative treatments for women's cancers
The company specializes in developing targeted therapeutics that aim to address the unique challenges and unmet needs in the treatment of gynecologic cancers, including ovarian and endometrial cancer. By harnessing advanced research and proprietary technologies, Context Therapeutics is committed to improving patient outcomes through the creation of personalized therapies that enhance the efficacy and safety of cancer treatment options.
Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter financial results. Quanex Building Products shares fell 10.7% to $30.95 on Friday.
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Friday. Here are some other big stocks recording gains in today’s session.
Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares rose 90.2% to $0.2297 in pre-market trading. Aerwins Technologies is considering strategic alternatives for non-core operations including, not limited to possible sale/other disposition of assets.
